Racemic mixtures and inefficient chemical resolutions lead to low yields of optically active intermediates required for pharmaceutical and agrochemical synthesis.

Inefficient synthesis and purification methods lead to residual impurities and low yields in macrocyclic gadolinium complex production.

Conventional synthetic routes for agrochemical and pharmaceutical intermediates suffer from low yields, excessive waste generation, and insufficient product purity.

Complex multi-step reactions and difficult purification requirements cause significant product loss and low chemical purity during large-scale manufacturing.